Muscle Oxygenation, Functional Capacity and Frailty in Kidney Transplant Recipients with and Without Inspiratory Muscle Weakness

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorHacettepe University

About this trial

The aim of this study was to compare respiratory function, muscle oxygenation, functional capacity, peripheral muscle strength, body composition, and frailty in kidney transplant recipients with and without inspiratory muscle weakness.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with kidney transplantation

At least 6 months after the kidney transplant

Not having regular exercise habits

Voluntary participation in the study

Disqualifiers

Having a musculoskeletal problem that may interfere with the tests

Having neurological impairment

Having chronic lung disease

Having had any cardiovascular event in the last 6 months

Trial population

Kidney transplant recipients will be included.

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

30 Participants
are grouped into 2 trial groups
Group A: Patients with inspiratory muscle weakness
Group B: Patients without inspiratory muscle weakness

Trial outcomes

Primary outcomes

1

Respiratory muscle strength

Maximal inspiratory pressure (MIP) will be measured using a portable mouth pressure measuring device.

Time frame
1st day
2

Respiratory muscle strength

Maximal expiratory pressure (MEP) will be measured using a portable mouth pressure measuring device.

Time frame
1st day
3

Functional capacity

Will be evaluated with 6 minute walk test.

Time frame
1st day
4

Peripheral muscle strength

Knee extensor strength will be measured using a hand dynamometer.

Time frame
1st day

Secondary outcomes

1

Forced expiratory volume in one second

Respiratory function will be evaluated using spirometry. Forced expiratory volume in one second will be recorded.

Time frame
1st day
2

Forced vital capacity

Respiratory function will be evaluated using spirometry. Forced vital capacity will be recorded.

Time frame
1st day
3

Forced expiratory volume in one second/forced vital capacity

Respiratory function will be evaluated using spirometry. Forced expiratory volume in one second/forced vital capacity will be recorded.

Time frame
1st day
4

Peak expiratory flow

Respiratory function will be evaluated using spirometry. Peak expiratory flow will be recorded.

Time frame
1st day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hacettepe University

Lead sponsor

Kirsehir Ahi Evran Universitesi

Sponsor institution